MedTrace Logo

Nudging Flu Vaccination in Patients at Moderately High Risk for Flu and Flu-related Complications

NCT05509283 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40671

Last updated 2022-12-05

No results posted yet for this study

Summary

This study will test the relative efficacy of high-risk messages in increasing flu shot rates in patients at moderately high risk for flu and complications (those in the top 11-20% of risk). It will also examine whether informing patients that their high-risk status was determined by analyzing their medical records or by an artificial intelligence (AI) / machine-learning (ML) algorithm analyzing their medical records will affect the likelihood of receiving a flu vaccine.

Conditions

  • Influenza
  • Vaccination
  • Health Promotion
  • Health Behavior
  • Risk Reduction

Interventions

BEHAVIORAL

Risk Reduction

Letter, patient portal, SMS and/or another modality

Sponsors & Collaborators

Principal Investigators

  • Christopher Chabris, PhD · Geisinger Clinic

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-09-13
Primary Completion
2022-10-26
Completion
2022-10-26

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05509283 on ClinicalTrials.gov